Product Overview: Boldenone 400 Mactropin
Boldenone 400 Mactropin is a high-concentration injectable anabolic steroid preparation containing boldenone undecylenate at 400mg/ml. This research compound belongs to the testosterone-derivative class of anabolic steroids, originally developed for veterinary applications but now extensively studied in laboratory settings. At Stroid UK Shop, researchers can access this Mactropin-manufactured compound for comprehensive in-vitro studies examining anabolic steroid mechanisms and tissue-selective androgenic activity.
Laboratory Applications
Research scientists investigating steroid biochemistry frequently study boldenone undecylenate for its unique pharmacological profile. The compound demonstrates prolonged activity due to its undecylenate ester chain, making it valuable for extended-duration laboratory experiments. Studies examining protein synthesis pathways, nitrogen retention mechanisms, and androgen receptor binding characteristics utilise this compound’s distinctive properties. Researchers in our steroid injections boldenone category find it particularly useful for comparative studies alongside other anabolic compounds. Laboratory investigations often examine its reduced aromatisation compared to testosterone derivatives, offering insights into selective tissue targeting mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Boldenone Undecylenate |
| Concentration | 400mg/ml |
| Manufacturer | Mactropin |
| CAS Number | 13103-34-9 |
| Molecular Formula | C₃₀H₄₄O₃ |
| Storage Requirements | Room temperature, protect from light |
Unlike compounds found in our SARMs or peptides categories, this steroid requires careful handling protocols and appropriate laboratory safety measures during research applications.
Research Compliance
This product is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper licensing and institutional approval before conducting studies with this compound.
